← 返回前沿论文

鼻咽癌中 TIL(肿瘤浸润淋巴细胞)的涌现:预测价值与免疫治疗意义

英文原题:The emergence of tumor-infiltrating lymphocytes in nasopharyngeal carcinoma: Predictive value and immunotherapy implications.

PubMed 2021/08/08(内容时间) Genes Dis Q1 · IF 14.6(JCR 2025)

研究概要

鼻咽癌(NPC)的临床研究常发现原发肿瘤部位有大量淋巴细胞浸润。

中文摘要

鼻咽癌(NPC)的临床研究常发现原发肿瘤部位有大量淋巴细胞浸润。作为肿瘤微环境的重要组成部分,TIL(肿瘤浸润淋巴细胞)(TILs)并非单独存在,而是作为一个具有高度异质性的复杂多细胞群体存在。TILs在NPC的发生、发展、侵袭和转移中发挥着极其重要的作用。最新研究表明,它们参与肿瘤发生和治疗,TILs亚群的组成、数量、功能状态和分布对NPC患者的预后具有良好的预测价值。TILs是TNM分期的独立预后因素,并与更好的预后显著相关。此外,使用抗肿瘤TILs的过继性免疫治疗已在包括NPC在内的多种实体瘤中取得了良好效果。本综述评估了NPC近期的临床和临床前研究,总结了TILs在促进和抑制肿瘤生长中的作用,评估了TILs的预测价值,并探讨了基于TILs的免疫治疗在NPC治疗中的潜在获益。

展开英文摘要原文

The clinical study of nasopharyngeal carcinoma (NPC) often reveals a large number of lymphocytes infiltrating the primary tumor site. As an important part of the tumor microenvironment, tumor-infiltrating lymphocytes (TILs) do not exist alone but as a complex multicellular population with high heterogeneity. TILs play an extremely significant role in the occurrence, development, invasion and metastasis of NPC. The latest research shows that they participate in tumorigenesis and treatment, and the composition, quantity, functional status and distribution of TILs subsets have good predictive value for the prognosis of NPC patients. TILs are an independent prognostic factor for TNM stage and significantly correlated with better prognosis. Additionally, adoptive immunotherapy using anti-tumor TILs has achieved good results in a variety of solid tumors including NPC. This review evaluates recent clinical and preclinical studies of NPC, summarizes the role of TILs in promoting and inhibiting tumor growth, evaluates the predictive value of TILs, and explores the potential benefits of TILs-based immunotherapy in the treatment of NPC.

论文信息

作者
Yang L、Liu G、Li Y、Pan Y
单位
Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan University, Wuhan, Hubei 430071, PR China.China
文献类型
综述
期刊
Genes & diseases2022 Sep
原文标识
PubMed 35873027 · DOI 10.1016/j.gendis.2021.07.002